• U.S. Intelligence Community's Report Inconclusive on COVID-19 Origins

    In May, the U.S. intelligence community (IC) was tasked by President Joe Biden to investigate the origins of CVID-19. On Tuesday, the IC delivered its assessment to the White House. The IC report is inconclusive, offering no definitive answer to the question of whether COVID-19 jumped to humans naturally, or was released from a lab.

  • Report: Lab-Leak Theory of COVID-19 Origins Lacking Evidence So Far

    A new scientific report says that the lab-leak theory of the origins of COVID-19 has, so far, no evidence to support it. “Preventing future pandemics requires the political will to cut off the routes by which these viruses enter the human population. Focusing on the wrong direction will preclude those efforts from occurring,” says the report’s lead author. Regarding the lab-leak theory, the researcher adds: “It can’t be dismissed entirely, but it is highly unlikely. There’s no evidence for it right now.”

  • What Scientists Do and Don’t Know about COVID-19 Origins | The Rise of the Coronavirus Lab-Leak Theory | The Lab Leak Theory Doesn’t Hold Up, and more

    Editor’s note: This is the first of a 2-part list of the best articles on the origins of COVID-19. Tomorrow we will publish the second part of the list.

    ·  The COVID Lab-Leak Hypothesis: What Scientists Do and Don’t Know

    ·  The Known Knowns, Known Unknowns, and Unknown Unknowns of COVID-19

    ·  The Lab Leak Theory Doesn’t Hold Up

    ·  How COVID-19’s Origins Were Obscured, by the East and the West

    ·  The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins

    ·  After the Lab-Leak Theory, U.S.-Chinese Relations Head Downhill

    ·  The Sudden Rise of the Coronavirus Lab-Leak Theory

    ·  China Is Pushing Its Own Coronavirus Lab Leak Theory in Latest Battle of Narratives

    ·  The Case against the Covid-19 Lab Leak Theory

    ·  Republican Report Says Coronavirus Leaked from China Lab; Scientists Still Probing Origins

    ·  The Right Way to Investigate the Origins of COVID-19

  • Large Pandemics Are More Likely Than We Thought

    The COVID-19 pandemic may be the deadliest viral outbreak the world has seen in more than a century. But statistically, such extreme events aren’t as rare as we may think. Most people are likely to experience an extreme pandemic like COVID-19 in their lifetime, a new study shows.

  • Data Mining Tools Tackle COVID-19 Misinformation, Identify Symptoms

    Computer scientists use Google Trends and a government dataset to track both COVID-19 symptoms and sift through misinformation about the disease on social media.

  • New Ways to Assess Climate Change Impacts on Agriculture

    Scientists agree climate change has a profound impact on U.S. agricultural production, but estimates vary, making it hard to develop mitigation strategies. Two agricultural economists take a closer look at how choice of statistical methodology influences climate study results. They also propose a more accurate and place-specific approach to data analysis.

  • CDC Sets Up New Disease Forecasting Center

    The CDC announced a new center — the Center for Forecasting and Outbreak Analytics — designed to advance the use of forecasting and outbreak analytics in public health decision making. Among other missions, the new center will accelerate access to and use of data for public health decision-makers who need information to mitigate the effects of disease threats, such as social and economic disruption.

  • Investments in Nature Needed to Stop the Next Pandemic: Experts

    A group of leading scientific experts from the U.S., Latin America, Africa and South Asia released a report outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people. Among other findings, the report notes that protecting forests and changing agricultural practices are essential, cost-effective actions to prevent pandemics.

  • COVID Vaccine Protection Waning Against Infection -- but Not Hospitalization

    One study of 2-dose vaccination with Pfizer/BioNTech and Moderna mRNA vaccines found significantly diminishing efficacy against infection in nursing home residents, while two other studies showed sustained protection against coronavirus-related hospitalizations but declining coverage against new adult cases.

  • U.S. Early COVID-19 Vaccine Campaign Prevented Nearly 140,000 Deaths

    The early U.S. COVID-19 vaccination campaign prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study. As a result of these early vaccination efforts, states experienced five fewer deaths from COVID-19 per 10,000 adult residents.

  • What the “Lyme Wars” Can Teach Us about COVID-19 and How to Find Common Ground in the School Reopening Debate

    As schools reopen, concerns over a delta-driven surge in cases, vaccine ineligibility for children younger than 12 and varying opinions about mask use in school settings loom large.The Lyme controversy offers four lessons on how parents, school districts, elected officials and scientists can find common ground – and a path forward – in the 2021-2022 school year.

  • Focusing on Zoonotic Diseases

    Experts warn that zoonotic diseases—diseases caused by germs that spread from animals to people—are a growing and increasingly dangerous threat to global public health. Veterinarian and PNNL data scientist Lauren Charles talks animal-borne diseases—and how biosurveillance can help combat them

  • Debate over Origins of COVID-19 Continues

    At the end of the month, the U.S. intelligence community (IC) will submit a report to President Joe Biden offering the IC’s conclusions regarding the origins of COVID-1. The report is not likely to put an end to the debate, especially since China is refusing access to key materials and personnel.

  • Parasites Fight Chemical and Biological Weapons

    Harnessing parasites to help soldiers and first responders counter chemical and biological weapon attacks in war zones.

  • Medicine Manufacturing Limits Poses Risk to U.S. Health Security

    More than 80 percent of the active ingredients in medicines the U.S. Food and Drug Administration deems essential for public health have no U.S. manufacturing source. Essential medicines include antibiotics, antivirals, blood pressure pills, steroids and many others. This vulnerability of the U.S. public health care system is not only matter of health care security, but of national security as well.